News & Events

Philogen to attend the Cytokine-Based Cancer Immunotherapies Summit on November 30-December 2 , 2021

Oct 5, 2021

Dario Neri, co-founder, CEO and CSO, is giving a presentation to address the question on how to achieve the therapeutic dose at the tumor site with cytokine-based targeted products.

Roberto De Luca, Head of Antibody Therapeutics at Philogen, is also giving a presentation focused on the antibody-based delivery of interferons for cancer therapy.

See cytokine-immunotherapies website for more details.